ArticleChemMedChem2026
Comprehensive Magnetic Resonance Imaging Relaxometry of Gadolinium-Based Contrast Agents: A Systematic Study of Transmetallation and Transchelation Processes With Zinc Ions and Heparin.
Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multinuclear NMR and MRI Beyond Proton Imaging: Principles, Contrast Mechanisms, and Applications in Materials and Biomedicine.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Gadolinium-based contrast agents (GBCAs) are essential in medical imaging, but concerns remain about their long-term safety. An increasing number of studies indicate that gadolinium can accumulate in human tissues. The initial step is transmetallation, whereby endogenous ions displace Gd(III) ions from its chelate. Subsequently, a transchelation process allows ion binding to macromolecules, such as glycosaminoglycans (GAGs), and tissue deposits may form. However, the clinical impact and potential connection to gadolinium deposition disease remain uncertain and require further research. In this study, magnetic resonance imaging relaxometry was employed to investigate the molecular interactions of eight clinically relevant GBCAs with Zn(II) ions and GAGs. Taking advantage of the characteristic relaxivity changes of Gd(III) ions in different environments enabled detection and quantification of free Gd(III) ions, as well as of the macromolecule-bound species. The investigation revealed distinct relaxivity patterns of Gd-accessible water that are specific for each GBCA, highlighting differences in intrinsic stability when challenged by competing ions or alternative chelators. Evaluation of transitions between equilibrium states enables comparative assessment of reaction kinetics for deeper insights into the observables of GBCA behavior. Thus, relaxometry emerges as a robust analytical platform, offering valuable guidance for improving existing contrast agents and designing safer, more stable alternatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.